1. Home
  2. SRPT vs SHOO Comparison

SRPT vs SHOO Comparison

Compare SRPT & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • SHOO
  • Stock Information
  • Founded
  • SRPT 1980
  • SHOO 1990
  • Country
  • SRPT United States
  • SHOO United States
  • Employees
  • SRPT N/A
  • SHOO N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • SHOO Shoe Manufacturing
  • Sector
  • SRPT Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • SRPT 1.7B
  • SHOO 1.8B
  • IPO Year
  • SRPT 1997
  • SHOO 1993
  • Fundamental
  • Price
  • SRPT $11.93
  • SHOO $26.87
  • Analyst Decision
  • SRPT Hold
  • SHOO Hold
  • Analyst Count
  • SRPT 28
  • SHOO 7
  • Target Price
  • SRPT $48.42
  • SHOO $27.00
  • AVG Volume (30 Days)
  • SRPT 13.9M
  • SHOO 1.5M
  • Earning Date
  • SRPT 08-06-2025
  • SHOO 07-30-2025
  • Dividend Yield
  • SRPT N/A
  • SHOO 3.13%
  • EPS Growth
  • SRPT N/A
  • SHOO N/A
  • EPS
  • SRPT N/A
  • SHOO 2.32
  • Revenue
  • SRPT $2,233,371,000.00
  • SHOO $2,284,080,000.00
  • Revenue This Year
  • SRPT $19.93
  • SHOO $12.44
  • Revenue Next Year
  • SRPT N/A
  • SHOO $8.22
  • P/E Ratio
  • SRPT N/A
  • SHOO $11.58
  • Revenue Growth
  • SRPT 59.15
  • SHOO 10.34
  • 52 Week Low
  • SRPT $10.42
  • SHOO $19.05
  • 52 Week High
  • SRPT $150.48
  • SHOO $50.01
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.15
  • SHOO 58.21
  • Support Level
  • SRPT $10.42
  • SHOO $26.08
  • Resistance Level
  • SRPT $14.54
  • SHOO $27.66
  • Average True Range (ATR)
  • SRPT 1.90
  • SHOO 0.93
  • MACD
  • SRPT 0.13
  • SHOO 0.14
  • Stochastic Oscillator
  • SRPT 12.14
  • SHOO 79.21

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: